REMEDY PHARMACEUTICALS INC has a total of 21 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in China, Japan and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and machines are ADENOBIO N V, MEDA PHARMA GMBH & CO KG and BODOR NICHOLAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | Japan | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Canada | 2 | |
#6 | Republic of Korea | 2 | |
#7 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Jacobson Sven Martin | 15 |
#2 | Sven Martin Jacobson | 4 |
#3 | Jacobson Martin Sven | 1 |
#4 | Ang Robert | 1 |
#5 | Jacobson Sven | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017062765A1 | Methods of treating injuries or conditions related to cns edema | |
CN101932308A | Improved formulations and methods for lyophilization and lyophilates provided thereby | |
WO2008046014A1 | Treatment of alzheimer's disease using compounds that reduce the activity of non-selective ca++- activated atp-sensitive cation channels regulated by sur1 receptors |